Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

Brieana M. Rowles; Robert L. Findling

doi:10.1002/ddrr.120

Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

Brieana M. Rowles, Robert L. Findling

Research output: Contribution to journal › Review article › peer-review

30 Scopus citations

Abstract

Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

Original language	English (US)
Pages (from-to)	273-282
Number of pages	10
Journal	Developmental Disabilities Research Reviews
Volume	16
Issue number	3
DOIs	https://doi.org/10.1002/ddrr.120
State	Published - 2010
Externally published	Yes

Keywords

Attention-deficit/hyperactivity disorder
Developmental disorder
Subaverage intelligence
Treatment

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Developmental and Educational Psychology
Psychiatry and Mental health

Access to Document

10.1002/ddrr.120

Cite this

Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. / Rowles, Brieana M.; Findling, Robert L.
In: Developmental Disabilities Research Reviews, Vol. 16, No. 3, 2010, p. 273-282.

Research output: Contribution to journal › Review article › peer-review

@article{c94214575c3c44cf8ad0ad23495b47d6,

title = "Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders",

abstract = "Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.",

keywords = "Attention-deficit/hyperactivity disorder, Developmental disorder, Subaverage intelligence, Treatment",

author = "Rowles, {Brieana M.} and Findling, {Robert L.}",

year = "2010",

doi = "10.1002/ddrr.120",

language = "English (US)",

volume = "16",

pages = "273--282",

journal = "Developmental Disabilities Research Reviews",

issn = "1940-5510",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

AU - Rowles, Brieana M.

AU - Findling, Robert L.

PY - 2010

Y1 - 2010

N2 - Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

AB - Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

KW - Attention-deficit/hyperactivity disorder

KW - Developmental disorder

KW - Subaverage intelligence

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=79952788922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952788922&partnerID=8YFLogxK

U2 - 10.1002/ddrr.120

DO - 10.1002/ddrr.120

M3 - Review article

C2 - 20981766

AN - SCOPUS:79952788922

SN - 1940-5510

VL - 16

SP - 273

EP - 282

JO - Developmental Disabilities Research Reviews

JF - Developmental Disabilities Research Reviews

IS - 3

ER -

Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this